Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 69 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

15%

7 of 47 completed with results

Key Signals

7 with results100% success

Data Visualizations

Phase Distribution

60Total
Not Applicable (32)
Early P 1 (4)
P 1 (10)
P 2 (8)
P 4 (6)

Trial Status

Completed47
Recruiting6
Unknown6
Not Yet Recruiting4
Withdrawn3
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 47 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT04596644Phase 2Suspended

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

NCT05527652Not ApplicableRecruiting

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

NCT07358195Early Phase 1Not Yet Recruiting

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

NCT07302477Not ApplicableCompleted

Human Milk Oligosaccharides (HMOs) - Post Marketing Study on Infants (NeHMO)

NCT03707262Phase 1Recruiting

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor

NCT04576507Phase 2Completed

Repeated Cannabis Administration on Experimental Pain and Abuse Liability

NCT05978908Phase 1Completed

Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults

NCT06232460Not ApplicableCompletedPrimary

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

NCT05960045Not ApplicableCompleted

Testing Tolerance in Cow Milk Protein Allergy Patients: Milk Ladder or Direct Milk Administration?

NCT06659978Completed

Human Factors Validation and Acceptability Testing of a Stimulation Device

NCT05644717Phase 4Recruiting

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

NCT06189170Early Phase 1Recruiting

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

NCT06815107Not ApplicableRecruitingPrimary

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

NCT05427253Phase 1Completed

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

NCT05088694Not ApplicableEnrolling By Invitation

The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.

NCT06722820Phase 1Not Yet Recruiting

Study to Evaluate LPH-5 in Healthy Subjects

NCT05105243Phase 1Completed

Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers

NCT03315221Phase 2Completed

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.

NCT06034951Not ApplicableCompletedPrimary

Acceptability and Tolerance Study of a High Energy Tube Feed with Food Derived Ingredients

NCT03952845Not ApplicableNot Yet RecruitingPrimary

Intranasal Capsaicinoid Spray

Scroll to load more

Research Network

Activity Timeline